Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National uniformity in House-passed bill close to Senate version.

This article was originally published in The Tan Sheet

Executive Summary

NATIONAL UNIFORMITY PROVISIONS IN HOUSE-PASSED FDA REFORM WILL MIRROR those in S 830, the Senate FDA reform bill cleared Sept. 23 by a vote of 98-2, with two exceptions. The House bill lacks an amendment similar to that attached to the Senate bill by Patty Murray (D-Wash.), which would require HHS to respond to states' petitions for exemptions to nationally uniform regs within 120 days ("The Tan Sheet" Sept. 29, p. 13). The House bill also does not contain language included in S 830 regarding the protection of "the health and safety of children" added by Murray.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087643

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel